A. Kengne
Endocrinology, Diabetes and Metabolism · 2002–2024
A researcher in the Science corpus: 25 papers; trusts 3 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Endocrinology, Diabetes and Metabolism — 93 citations into it
- Epidemiology — 57 citations into it
- Statistics and Probability — 39 citations into it; #12,928 of 12,932 by trust here, #4,650 by citations
- Economics and Econometrics — 34 citations into it; #8,722 of 23,481 by trust here, #4,336 by citations
Whom A. Kengne trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Karel G. M. Moons
- Michael J. Pencina
- Esteban Walker
- Douglas G. Altman
- Ralph B. D’Agostino
- Patrick Royston
- Y. Vergouwe
Who trusts A. Kengne overall
- Gary S. Collins
- Johannes B Reitsma
- Karel G. M. Moons
- Douglas G. Altman
- P. Mohapatra
- T. Debray
- Baijayantimala Mishra
- M. Shipe
Papers from A. Kengne's perspective
Ordered by how strongly the researchers A. Kengne trusts endorse each paper. Same corpus, a different order for every researcher.
- Value of assessment of pretest probability of deep-vein thrombosis in clinical management.
- Regression Modeling Strategies (Technometrics)
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers (Statistics in Medicine)
- Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate (Annals of Internal Medicine)
- The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). (Clinical science)
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond (Statistics in Medicine)
- Presentation of multivariate data for clinical use: The Framingham Study risk score functions
- Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions
- Updating methods improved the performance of a clinical prediction model in new patients. (Journal of Clinical Epidemiology)
- Clinical Prediction Models
Their papers
- Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker (2012) — 850 citations
- Risk prediction models: II. External validation, model updating, and impact assessment (2012) — 1,118 citations
- Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants (2024) — 676 citations
- Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) — 1,604 citations
- The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action (2019) — 898 citations
- Rising rural body-mass index is the main driver of the global obesity epidemic in adults (2019) — 617 citations
- The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2019) — 1,458 citations
- World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions (2019) — 908 citations
- Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017. (2019) — 742 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) — 2,198 citations
- Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. (2018) — 844 citations
- Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 632 citations
- Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants (2016) — 4,573 citations
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) — 4,590 citations
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. (2016) — 5,345 citations
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants (2016) — 3,268 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015 (2016) — 1,771 citations
- A century of trends in adult human height (2016) — 1,174 citations
- Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. (2015) — 627 citations
- Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014) — 737 citations